Why is Natco Pharma falling/rising?

As of 01-Jul, Natco Pharma Ltd. has experienced a price increase, with its current price at 936.95, reflecting a rise of 9.65 or 1.04%. The stock has been gaining momentum, having outperformed its sector by 1.25% today and achieving a consecutive gain over the last three days, resulting in a total return of 7.49% during this period. Additionally, the stock's performance over the past week shows a significant increase of 7.69%, while its one-month return stands at 6.06%. The company benefits from high management efficiency, indicated by a return on equity (ROE) of 15.57%, a low debt-to-equity ratio, and healthy long-term growth with an annual operating profit increase of 32.35%. Furthermore, the stock is trading at a discount compared to its peers, with a PEG ratio of 0.3, which suggests attractive valuation metrics.
In the broader market context, Natco Pharma's recent performance has outpaced the benchmark Sensex, which has only increased by 2.00% over the past week. This indicates that investor sentiment towards Natco Pharma is relatively strong, especially given the rising investor participation, as evidenced by a 153.23% increase in delivery volume compared to the five-day average. Despite a year-to-date decline of 32.45%, the stock's recent gains suggest a potential recovery phase, supported by high institutional holdings at 23.15%, which may provide additional stability and confidence in the stock's fundamentals.